Approved Drug Products with Therapeutic Equivalence Evaluation
The sixth edition of the FDA publication now contains patent information, NDA numbers, approval dates, exclusivity information, and therapeutic equivalence evaluations for multiple source drug products. List is available from the Superintendent of Documents, U.S. Govt. Printing Office, Washington, D.C. 20402 and should be requested by name. Subscription fee is $103 ($128.75 for foreign subscriptions), which also covers monthly cumulative supplements.
You may also be interested in...
CRLs FDA submits in response to ANDAs increased most years since FY 2015, though FY 2020 total likely will be lower than two previous years. A 2019 CRL interrupted GSK's plans to market first mouth spray nicotine replacement therapy in US.
The US FDA appears to have concerns about the device used to administer the vaccine.
The US Medicare agency has released a quick-start guide for laboratory certification.